Biofrontera Inc. (NASDAQ:BFRI) Q4 2022 Earnings Call Transcript

Erica Monaco: so I think we — where we were seeing that slower in the earlier phases, it was because we were still working back and forth with the FDA on the protocol and we did go through an amendment not too long ago. So now you are looking at what I would think is reasonable cadence for enrollment and treatment.

Bruce Jackson: All right. Great. That’s it for me. Thank you for taking my questions.

Operator: Thank you. As we have no further questions in the queue at this time, I’ll hand it back to Erica Monaco for any closing comments.

Erica Monaco: Thank you and thank you all for the questions and thank you again everyone for your time today. In closing, we remain laser focused on our business, commercial and financial goals. We are off to a great start in 2023 and look forward to a year filled with growth and momentum. Fred and I will be participating in the 35th Annual Roth Conference next week from March 12th to the 14th. We look forward to meeting with investors and will be onsite and available for one-on-one meetings. Please contact your Roth MKM representative to arrange a meeting. At the conference, we will also be participating in a fireside chat and we’ll share a link to view this webcast on Biofrontera’s IR website when it becomes available. Biofrontera will also be hosting a booth at the 2023 AAD Annual Meeting in New Orleans from March 17 to March 21.

Myself and our commercial leadership will be meeting with customers, physicians and industry colleagues throughout the conference. So please stop by the booth and say hello if you are there. If we don’t see you at these two events or you’re unable to tune in our — tune into our Roth conference webcast, we look forward to speaking with you again when we report our 2023 first quarter results in May. In the meantime, thank you again for joining us today.

Operator: Thank you everyone. This does conclude today’s call. You may disconnect your lines at this time and have a wonderful day and we thank you for your participation.